Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Antiviral Chemistry & Chemotherapy|January 8, 2010
Factors affecting template usage in the development of K65R resistance in subtype C variants of HIV type-1Dimitrios Coutsinos, Cédric F Invernizzi, Hongtao Xu, et al.
The Journal of Antimicrobial Chemotherapy|April 15, 2021
Cell culture selections reveal favourable drug resistance profiles for doravirine and islatravirBluma G Brenner, Maureen Oliveira, Ruxandra-Ilinca Ibanescu, et al.
Virologie (Montrouge, France)|August 25, 2021
[L'usage de papier buvard de type « FTATM Classic » pour la détection et le génotypage du VIH chez des hommes ayant des relations sexuelles avec d'autres hommes à Montréal (Québec, Canada)]Frédéric Ohnona, Daniela Moisi, Ilinca Ibanescu, et al.
AIDS (London, England)|June 13, 2018
Durable suppression of HIV-1 with resistance mutations to integrase inhibitors by dolutegravir following drug washoutNathan Osman, Thibault Mesplède, Maureen Oliveira, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Differential maintenance of the M184V substitution in the reverse transcriptase of human immunodeficiency virus type 1 by various nucleoside antiretroviral agents in tissue cultureMarco Petrella, Maureen Oliveira, Daniela Moisi, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2009
Apricitabine does not select additional drug resistance mutations in tissue culture in human immunodeficiency virus type 1 variants containing K65R, M184V, or M184V plus thymidine analogue mutationsMaureen Oliveira, Daniela Moisi, Bonnie Spira, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
Lack of effect of recombinant human growth hormone on the in vitro activities of antiretroviral drugs against human immunodeficiency virus type 1Mark A Wainberg, Bluma G Brenner, Eric Daar, et al.
The Journal of Infectious Diseases|September 22, 2009
Signature nucleotide polymorphisms at positions 64 and 65 in reverse transcriptase favor the selection of the K65R resistance mutation in HIV-1 subtype CCédric F Invernizzi, Dimitrios Coutsinos, Maureen Oliveira, et al.
AIDS Research and Human Retroviruses|October 31, 2003
Drug resistance profiles of recombinant reverse transcriptases from human immunodeficiency virus type 1 subtypes A/E, B, and CYudong Quan, Bluma G Brenner, Richard G Marlink, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
M184I/V substitutions and E138K/M184I/V double substitutions in HIV reverse transcriptase do not significantly affect the antiviral activity of EFdAMaureen Oliveira, Bluma G Brenner, Hongtao Xu, et al.
Pageof 7